Catalyst Wire Dossier Catalyst Wire Dossier

Oxervate

cenegermin · Dompé Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Oxervate, covering 2018-08-22 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED [Phase 3]

See pricing